Abstract: A paste extruding device for a tubular positive plate includes a plate main body. The plate main body includes a cross beam, ribs and a tab. The ribs are linearly distributed on a bottom surface of the cross beam, and the tab is provide on a top surface of the cross beam. A processing tube is sleeved outside the rib, and the processing tube has a cavity shell structure with an open top. A filling cavity is formed between the rib and the processing tube, and a sliding groove is provided at a vertical central line of an outer wall of the processing tube. A processing sliding base is slidably sleeved on the outer wall of the processing tube. A paste extruding cavity is provided at an inner top of the processing sliding base, and a cooling cavity is provided at an inner bottom of the processing sliding base.

Abstract: A paste extruding device for a tubular positive plate includes a plate main body. The plate main body includes a cross beam, ribs and a tab. The ribs are linearly distributed on a bottom surface of the cross beam, and the tab is provide on a top surface of the cross beam. A processing tube is sleeved outside the rib, and the processing tube has a cavity shell structure with an open top. A filling cavity is formed between the rib and the processing tube, and a sliding groove is provided at a vertical central line of an outer wall of the processing tube. A processing sliding base is slidably sleeved on the outer wall of the processing tube. A paste extruding cavity is provided at an inner top of the processing sliding base, and a cooling cavity is provided at an inner bottom of the processing sliding base.

Abstract: Provided herein are antibodies and antigen binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms. Also provided are compositions with increased half-life, as well as compositions and methods for diagnosing and treating diseases associated with HER3 mediated signal transduction.

Abstract: The present invention relates to antibodies and antigen binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms. Also provided are compositions with increased half-life. In addition, the invention provides compositions and methods for diagnosing and treating diseases associated with HER3 mediated signal transduction.

Abstract: The present invention relates to antibodies and antigen binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms. Also provided are compositions with increased half-life. In addition, the invention provides compositions and methods for diagnosing and treating diseases associated with HER3 mediated signal transduction.

Abstract: The present invention relates to antibodies and antigen binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms. Also provided are compositions with increased half-life. In addition, the invention provides compositions and methods for diagnosing and treating diseases associated with HER3 mediated signal transduction.

Abstract: Provided herein are antibodies and antigen binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms. Also provided are compositions with increased half-life, as well as compositions and methods for diagnosing and treating diseases associated with HER3 mediated signal transduction.

Abstract: The present invention relates to antibodies and antigen binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms. Also provided are compositions with increased half-life. In addition, the invention provides compositions and methods for diagnosing and treating diseases associated with HER3 mediated signal transduction.

Abstract: The present invention relates to antibodies and antigen binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms. Also provided are compositions with increased half-life. In addition, the invention provides compositions and methods for diagnosing and treating diseases associated with HER3 mediated signal transduction.

Abstract: The present invention relates to antibodies and antigen binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms. Also provided are compositions with increased half-life. In addition, the invention provides compositions and methods for diagnosing and treating diseases associated with HER3 mediated signal transduction.